BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22038845)

  • 1. α-Tocopheryloxyacetic acid is superior to α-tocopheryl succinate in suppressing HER2-high breast carcinomas due to its higher stability.
    Dong LF; Grant G; Massa H; Zobalova R; Akporiaye E; Neuzil J
    Int J Cancer; 2012 Sep; 131(5):1052-8. PubMed ID: 22038845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma- and delta-tocotrienols exert a more potent anticancer effect than alpha-tocopheryl succinate on breast cancer cell lines irrespective of HER-2/neu expression.
    Pierpaoli E; Viola V; Pilolli F; Piroddi M; Galli F; Provinciali M
    Life Sci; 2010 Apr; 86(17-18):668-75. PubMed ID: 20188744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary administration of the proapoptotic vitamin E analogue alpha-tocopheryloxyacetic acid inhibits metastatic murine breast cancer.
    Hahn T; Szabo L; Gold M; Ramanathapuram L; Hurley LH; Akporiaye ET
    Cancer Res; 2006 Oct; 66(19):9374-8. PubMed ID: 17018590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A peptide conjugate of vitamin E succinate targets breast cancer cells with high ErbB2 expression.
    Wang XF; Birringer M; Dong LF; Veprek P; Low P; Swettenham E; Stantic M; Yuan LH; Zobalova R; Wu K; Ledvina M; Ralph SJ; Neuzil J
    Cancer Res; 2007 Apr; 67(7):3337-44. PubMed ID: 17409443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vitamin E analog, alpha-tocopheryloxyacetic acid enhances the anti-tumor activity of trastuzumab against HER2/neu-expressing breast cancer.
    Hahn T; Bradley-Dunlop DJ; Hurley LH; Von-Hoff D; Gately S; Mary DL; Lu H; Penichet ML; Besselsen DG; Cole BB; Meeuwsen T; Walker E; Akporiaye ET
    BMC Cancer; 2011 Nov; 11():471. PubMed ID: 22044845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin E analogs trigger apoptosis in HER2/erbB2-overexpressing breast cancer cells by signaling via the mitochondrial pathway.
    Wang XF; Witting PK; Salvatore BA; Neuzil J
    Biochem Biophys Res Commun; 2005 Jan; 326(2):282-9. PubMed ID: 15582575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrially targeted vitamin E succinate modulates expression of mitochondrial DNA transcripts and mitochondrial biogenesis.
    Truksa J; Dong LF; Rohlena J; Stursa J; Vondrusova M; Goodwin J; Nguyen M; Kluckova K; Rychtarcikova Z; Lettlova S; Spacilova J; Stapelberg M; Zoratti M; Neuzil J
    Antioxid Redox Signal; 2015 Apr; 22(11):883-900. PubMed ID: 25578105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (+)α-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex I and is as effective as arsenic trioxide or ATRA against acute promyelocytic leukemia in vivo.
    dos Santos GA; Abreu e Lima RS; Pestana CR; Lima AS; Scheucher PS; Thomé CH; Gimenes-Teixeira HL; Santana-Lemos BA; Lucena-Araujo AR; Rodrigues FP; Nasr R; Uyemura SA; Falcão RP; de Thé H; Pandolfi PP; Curti C; Rego EM
    Leukemia; 2012 Mar; 26(3):451-60. PubMed ID: 21869839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal formulation of alpha-tocopheryl maleamide: in vitro and in vivo toxicological profile and anticancer effect against spontaneous breast carcinomas in mice.
    Turánek J; Wang XF; Knötigová P; Koudelka S; Dong LF; Vrublová E; Mahdavian E; Procházka L; Sangsura S; Vacek A; Salvatore BA; Neuzil J
    Toxicol Appl Pharmacol; 2009 Jun; 237(3):249-57. PubMed ID: 19480910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial-dependent anticancer activity of δ-tocotrienol and its synthetic derivatives in HER-2/neu overexpressing breast adenocarcinoma cells.
    Viola V; Ciffolilli S; Legnaioli S; Piroddi M; Betti M; Mazzini F; Pierpaoli E; Provinciali M; Galli F
    Biofactors; 2013; 39(4):485-93. PubMed ID: 23361894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E Succinate and vitamin E analogue, alpha-TEA.
    Anderson K; Simmons-Menchaca M; Lawson KA; Atkinson J; Sanders BG; Kline K
    Cancer Res; 2004 Jun; 64(12):4263-9. PubMed ID: 15205340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoemulsion enhances α-tocopherol succinate bioavailability in rats.
    Gao Y; Qi X; Zheng Y; Ji H; Wu L; Zheng N; Tang J
    Int J Pharm; 2016 Dec; 515(1-2):506-514. PubMed ID: 27746330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-tocopheryl succinate selectively induces apoptosis in neuroblastoma cells: potential therapy of malignancies of the nervous system?
    Swettenham E; Witting PK; Salvatore BA; Neuzil J
    J Neurochem; 2005 Sep; 94(5):1448-56. PubMed ID: 16001965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of tumor growth in vivo by the mitocan alpha-tocopheryl succinate requires respiratory complex II.
    Dong LF; Freeman R; Liu J; Zobalova R; Marin-Hernandez A; Stantic M; Rohlena J; Valis K; Rodriguez-Enriquez S; Butcher B; Goodwin J; Brunk UT; Witting PK; Moreno-Sanchez R; Scheffler IE; Ralph SJ; Neuzil J
    Clin Cancer Res; 2009 Mar; 15(5):1593-600. PubMed ID: 19223492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo.
    Weber T; Lu M; Andera L; Lahm H; Gellert N; Fariss MW; Korinek V; Sattler W; Ucker DS; Terman A; Schröder A; Erl W; Brunk UT; Coffey RJ; Weber C; Neuzil J
    Clin Cancer Res; 2002 Mar; 8(3):863-9. PubMed ID: 11895920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrially targeted vitamin E succinate efficiently kills breast tumour-initiating cells in a complex II-dependent manner.
    Yan B; Stantic M; Zobalova R; Bezawork-Geleta A; Stapelberg M; Stursa J; Prokopova K; Dong L; Neuzil J
    BMC Cancer; 2015 May; 15():401. PubMed ID: 25967547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production.
    Gruber J; Staniek K; Krewenka C; Moldzio R; Patel A; Böhmdorfer S; Rosenau T; Gille L
    Bioorg Med Chem; 2014 Jan; 22(2):684-91. PubMed ID: 24393721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.
    Moulder SL; Yakes FM; Muthuswamy SK; Bianco R; Simpson JF; Arteaga CL
    Cancer Res; 2001 Dec; 61(24):8887-95. PubMed ID: 11751413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Combination of α-Tocopheryl Succinate and Sodium Selenite on Breast Cancer: A Merit or a Demerit?
    Badr DM; Hafez HF; Agha AM; Shouman SA
    Oxid Med Cell Longev; 2016; 2016():4741694. PubMed ID: 27127548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial targeting of α-tocopheryl succinate enhances its anti-mesothelioma efficacy.
    Kovarova J; Bajzikova M; Vondrusova M; Stursa J; Goodwin J; Nguyen M; Zobalova R; Pesdar EA; Truksa J; Tomasetti M; Dong LF; Neuzil J
    Redox Rep; 2014 Jan; 19(1):16-25. PubMed ID: 24225203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.